Terazosin

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 937 publications

A Propensity Score-Matched Protocol: Terazosin Plus Finasteride For Benign Prostatic Hyperplasia - Sex Hormone And Urinary Control Effects.

A Propensity Score-Matched Protocol: Terazosin Plus Finasteride For Benign Prostatic Hyperplasia - Sex Hormone And Urinary Control Effects.

Journal: Journal of visualized experiments : JoVE
Published: June 22, 2026

Disproportionality analysis of drug-associated tinnitus safety signals: a 43-year pharmacovigilance study.

Disproportionality analysis of drug-associated tinnitus safety signals: a 43-year pharmacovigilance study.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: April 23, 2026

Terazosin drives sex-dependent adrenergic-bioenergetic reprogramming to restore network function in Alzheimer's disease.

Terazosin drives sex-dependent adrenergic-bioenergetic reprogramming to restore network function in Alzheimer's disease.

Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026

Terazosin as a Non-Hormonal Treatment for Endometriosis.

Terazosin as a Non-Hormonal Treatment for Endometriosis.

Journal: International journal of molecular sciences
Published: April 03, 2026

Integrative In Silico Identification of TP53-Associated Drug Repurposing Candidates in Lung Adenocarcinoma.

Integrative In Silico Identification of TP53-Associated Drug Repurposing Candidates in Lung Adenocarcinoma.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 31, 2026

Efficacy of alpha-blockers in medical expulsive therapy for ureteral stones: A systematic review and meta-analysis of randomized controlled trials between 2010 and 2025.

Efficacy of alpha-blockers in medical expulsive therapy for ureteral stones: A systematic review and meta-analysis of randomized controlled trials between 2010 and 2025.

Journal: Arab journal of urology
Published: January 09, 2026

Non-Catalytic Inhibitors of the p38/MK2 Interface: Repurposing Approved Drugs to Target Neuroinflammation in Alzheimer's Disease.

Non-Catalytic Inhibitors of the p38/MK2 Interface: Repurposing Approved Drugs to Target Neuroinflammation in Alzheimer's Disease.

Journal: Journal of medicinal chemistry
Published: December 05, 2025

A Green GLANCE-Assisted Spectrofluorimetric Method for the Nanogram-Level Quantification of Terazosin, Singly and in Combination With Triamterene, With Therapeutic Drug Monitoring Applications: Greenness, Whiteness, and Blueness Assessment.

A Green GLANCE-Assisted Spectrofluorimetric Method for the Nanogram-Level Quantification of Terazosin, Singly and in Combination With Triamterene, With Therapeutic Drug Monitoring Applications: Greenness, Whiteness, and Blueness Assessment.

Journal: Luminescence : the journal of biological and chemical luminescence
Published: November 30, 2025

Effects of Prazosin and Other Alpha-1 Adrenergic Antagonist Drugs on Nightmares and Sleep Disturbances in Posttraumatic Stress Disorder.

Effects of Prazosin and Other Alpha-1 Adrenergic Antagonist Drugs on Nightmares and Sleep Disturbances in Posttraumatic Stress Disorder.

Journal: Journal of clinical psychopharmacology
Published: October 22, 2025

Synergistic Effects of Compound Dendrobium Candidum and Antihypertensive Medications on Refractory Hypertension in Spontaneously Hypertensive Rats.

Synergistic Effects of Compound Dendrobium Candidum and Antihypertensive Medications on Refractory Hypertension in Spontaneously Hypertensive Rats.

Journal: Cardiology research and practice
Published: September 25, 2025

Differential Risks of Dementia, Depression, and Injury Among Common α-Blockers, with Tamsulosin as the Reference Drug: A Real-World Cohort Study in Men with Lower Urinary Tract Symptoms.

Differential Risks of Dementia, Depression, and Injury Among Common α-Blockers, with Tamsulosin as the Reference Drug: A Real-World Cohort Study in Men with Lower Urinary Tract Symptoms.

Journal: Journal of clinical medicine
Published: September 24, 2025

APOE4 reduces hippocampal expression of phosphoglycerate kinase 1 and sodium potassium pump to enhance seizure susceptibility in mice.

APOE4 reduces hippocampal expression of phosphoglycerate kinase 1 and sodium potassium pump to enhance seizure susceptibility in mice.

Journal: Neurobiology of disease
Published: September 16, 2025
Showing 1-12 of 937

Last Updated: 06/30/2026